Targeting of Both the C-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice

Cancers - Switzerland
doi 10.3390/cancers2042153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

MET-EGFR Dimerization in Lung Adenocarcinoma Is Dependent on EGFR Mtations and Altered by MET Kinase Inhibition

PLoS ONE
Multidisciplinary
2017English

Dual Inhibition of EGFR and mTOR Pathways in Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

The Persistent Promise of Combining HGF/MET and EGFR Inhibition in Non-Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Inhibition of EGFR Induces a C-Met-Driven Stem Cell Population in Glioblastoma

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2014English

Everolimus Prolonged Survival in Transgenic Mice With EGFR-driven Lung Tumors

Experimental Cell Research
Cell Biology
2014English

Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Inhibition of Lung Tumor Growth in Nude Mice by siRNACD31 Targeting PECAM‑1

Oncology Letters
Cancer ResearchOncology
2014English

Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

Chemopreventive Effects of Gefitinib on Nonsmoking-Related Lung Tumorigenesis in Activating Epidermal Growth Factor Receptor Transgenic Mice

Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy